FDA Brief

Warning letters Drugs

FDA warning letter to

OSRX, Inc.

Issued Apr 23, 2025Posted May 13, 2025Center for Drug Evaluation and Research (CDER)

Compounding Pharmacy/Adulterated Drug Products. We haven't summarized this letter yet. Read it on fda.gov.